Streetbeat News

RMHB

Rocky Mountain High Brands Inc

http://rockymountainhighbrands.com/

Employees

5

Industry

Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers

Open

0.01

Mkt cap

4.3M

Volume

50K

High

0.01

P/E Ratio

-0.18

52-wk high

0.02

Low

0.01

Div yield

N/A

52-wk low

0.00

Cannabis stocks experienced significant movements on January 19, 2024. EVIO led the gainers with a 9900.00% increase, while Rocky Mountain High topped the losers with a 21.62% decline. Notable gainers included Genetic Technologies, OrganiGram Holdings, and Cara Therapeutics, with increases of 42.16%, 10.72%, and 4.80% respectively. Among the losers, Corbus Pharmaceuticals and Greenlane Holdings saw declines of 4.91% and 3.32%.

Portfolio Pulse from Benzinga Insights

January 19, 2024 | 9:30 pm

On January 17, 2024, several cannabis stocks experienced significant price movements. AusCann Group Holdings led the gainers with a 187.50% increase, while MedMen Enterprises and GreenGro Technologies were the biggest losers, both dropping by over 99%. Other notable gainers include Khiron Life Sciences and Maple Leaf Green World, with increases of 54.29% and 32.45%, respectively. Among the losers, 22nd Century Group and OrganiGram Holdings saw declines of 14.72% and 7.89%. The movements reflect the volatile nature of the cannabis market.

Portfolio Pulse from Benzinga Insights

January 17, 2024 | 9:30 pm

Marijuana stocks saw significant movement on January 15, 2024, with Khiron Life Sciences leading the gainers with a 152.73% increase, while MedMen Enterprises experienced a steep decline of 95.71%. Other notable gainers include Global Compliance, CordovaCann, and RIV Capital. The losers' list was topped by AusCann Group Holdings with a 58.82% drop, followed by EnWave and Auxly Cannabis Group.

Portfolio Pulse from Benzinga Insights

January 15, 2024 | 9:30 pm

Cannabis stocks experienced significant movements on January 12, 2024. Khiron Life Sciences led the gainers with a 152.73% increase, while MedMen Enterprises saw a dramatic 95.71% drop. Other notable gainers include Global Compliance and CordovaCann. Among the losers, AusCann Group Holdings also faced a steep decline. The volatility in these stocks reflects ongoing developments in the cannabis industry.

Portfolio Pulse from Benzinga Insights

January 12, 2024 | 9:30 pm

On January 11, 2024, several cannabis stocks experienced significant movements. Notable gainers included Heritage Cannabis Holding, Blueberries Medical, OrganiGram Holdings, and others, with increases ranging from 3.12% to 26.58%. Conversely, several companies faced declines, with Global Compliance leading the losers, followed by Rocky Mountain High, CLS Holdings USA, and others, with decreases ranging from 3.07% to 16.57%. The article lists the closing prices and percentage changes for each mentioned company.

Portfolio Pulse from Benzinga Insights

January 11, 2024 | 9:30 pm

The marijuana stock market saw significant movements on January 9, 2024, with a mix of gainers and losers. Notable gainers included AusCann Group Holdings, Rocky Mountain High, and Item 9 Labs with substantial percentage increases in their share prices. On the other hand, Australis Capital and Choom Holdings experienced dramatic declines, with Australis Capital shares closing down 100%. Other notable losers included Tilray Brands, Canopy Growth, and SNDL with significant percentage decreases. This market activity reflects the volatile nature of the marijuana industry stocks.

Portfolio Pulse from Benzinga Insights

January 09, 2024 | 9:30 pm

Marijuana stocks experienced significant movement on a recent Monday, with Australis Capital, EVIO, and several others posting substantial gains, while a few companies like Rocky Mountain High and MJ Holdings faced declines. The article lists the percentage changes and closing prices for the gainers and losers in the sector.

Portfolio Pulse from Benzinga Insights

January 08, 2024 | 9:30 pm

Cannabis stocks experienced significant movements on January 4, 2024. EVIO led the gainers with a 4900% increase, while AusCann Group Holdings saw the largest decline, dropping 37.98%. Other notable gainers include Khiron Life Sciences and Cannabix Technologies. Among the losers, Psychemedics and Global Compliance also saw substantial drops in their share prices.

Portfolio Pulse from Benzinga Insights

January 04, 2024 | 9:30 pm

The article lists the cannabis stocks that experienced significant gains and losses on January 2, 2024. Notable gainers include Global Hemp Group, Khiron Life Sciences, and 1933 Industries, with increases of 238.24%, 50.00%, and 31.82% respectively. On the losing side, Item 9 Labs, AusCann Group Holdings, and Blueberries Medical saw declines of 18.42%, 14.67%, and 10.29%. The article also mentions several other cannabis-related companies with smaller gains and losses.

Portfolio Pulse from Benzinga Insights

January 02, 2024 | 9:30 pm

On December 28, 2023, several cannabis stocks experienced significant price movements. Notable gainers included GrowLife, Rhinomed, AusCann Group Holdings, Khiron Life Sciences, and Cara Therapeutics, with GrowLife leading the surge with a 200% increase. On the losing end, The Flowr Corporation saw a dramatic 99.99% decline. Other decliners included CordovaCann, Rocky Mountain High, and Item 9 Labs. The cannabis sector showed high volatility with these sharp price changes.

Portfolio Pulse from Benzinga Insights

December 28, 2023 | 9:30 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.